 Patrick Ng
Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antidotes | 12 | 2021 | 139 | 3.870 |
Why?
| | Potassium Cyanide | 4 | 2021 | 18 | 1.700 |
Why?
| | Hydrogen Sulfide | 3 | 2020 | 41 | 1.630 |
Why?
| | Thiosulfates | 2 | 2021 | 18 | 1.600 |
Why?
| | Poison Control Centers | 2 | 2019 | 98 | 1.310 |
Why?
| | Swine | 9 | 2021 | 719 | 1.280 |
Why?
| | Cyanides | 4 | 2021 | 42 | 1.250 |
Why?
| | Cobamides | 3 | 2020 | 22 | 1.120 |
Why?
| | Air Ambulances | 2 | 2022 | 42 | 1.090 |
Why?
| | Military Personnel | 7 | 2023 | 399 | 0.870 |
Why?
| | Brain Injuries, Traumatic | 2 | 2022 | 244 | 0.830 |
Why?
| | Chemically-Induced Disorders | 1 | 2019 | 2 | 0.770 |
Why?
| | Aluminum Compounds | 1 | 2019 | 24 | 0.750 |
Why?
| | Electron Transport Complex IV | 1 | 2019 | 71 | 0.750 |
Why?
| | Phosphines | 1 | 2019 | 30 | 0.740 |
Why?
| | Psychotropic Drugs | 1 | 2019 | 58 | 0.730 |
Why?
| | Pesticides | 1 | 2019 | 66 | 0.710 |
Why?
| | Glycine | 1 | 2019 | 157 | 0.700 |
Why?
| | Carbon Monoxide Poisoning | 1 | 2018 | 9 | 0.700 |
Why?
| | Military Facilities | 1 | 2017 | 5 | 0.690 |
Why?
| | Tablets | 1 | 2017 | 36 | 0.680 |
Why?
| | Hydrocodone | 1 | 2017 | 16 | 0.680 |
Why?
| | Drug Overdose | 2 | 2019 | 266 | 0.600 |
Why?
| | Arrhythmias, Cardiac | 1 | 2019 | 328 | 0.600 |
Why?
| | Seizures | 1 | 2019 | 329 | 0.590 |
Why?
| | Environmental Exposure | 1 | 2019 | 394 | 0.560 |
Why?
| | Administration, Oral | 5 | 2021 | 798 | 0.560 |
Why?
| | Substance-Related Disorders | 2 | 2019 | 975 | 0.520 |
Why?
| | Disease Models, Animal | 5 | 2020 | 3826 | 0.510 |
Why?
| | Opioid-Related Disorders | 1 | 2017 | 329 | 0.450 |
Why?
| | Analgesics, Opioid | 2 | 2017 | 725 | 0.430 |
Why?
| | Apnea | 2 | 2020 | 23 | 0.380 |
Why?
| | Sulfides | 2 | 2021 | 99 | 0.380 |
Why?
| | Injections, Intramuscular | 5 | 2020 | 123 | 0.370 |
Why?
| | Emergency Medical Services | 3 | 2021 | 522 | 0.360 |
Why?
| | Antiemetics | 2 | 2019 | 35 | 0.360 |
Why?
| | Sulfhydryl Compounds | 2 | 2020 | 180 | 0.350 |
Why?
| | Airway Management | 2 | 2018 | 45 | 0.340 |
Why?
| | Hospitals, Military | 2 | 2018 | 38 | 0.340 |
Why?
| | Nausea | 2 | 2018 | 116 | 0.330 |
Why?
| | Poisoning | 2 | 2018 | 120 | 0.330 |
Why?
| | Kaplan-Meier Estimate | 2 | 2018 | 900 | 0.290 |
Why?
| | Humans | 28 | 2023 | 115146 | 0.280 |
Why?
| | Iraq War, 2003-2011 | 2 | 2022 | 132 | 0.260 |
Why?
| | Retrospective Studies | 7 | 2023 | 11727 | 0.260 |
Why?
| | Critical Care | 3 | 2023 | 518 | 0.250 |
Why?
| | Animals | 11 | 2021 | 34755 | 0.230 |
Why?
| | Aromatherapy | 2 | 2019 | 2 | 0.230 |
Why?
| | Sodium Bicarbonate | 2 | 2019 | 48 | 0.220 |
Why?
| | Random Allocation | 2 | 2020 | 396 | 0.220 |
Why?
| | Ondansetron | 2 | 2019 | 15 | 0.220 |
Why?
| | Wounds and Injuries | 2 | 2021 | 896 | 0.220 |
Why?
| | Female | 16 | 2020 | 63296 | 0.220 |
Why?
| | Physostigmine | 1 | 2020 | 11 | 0.210 |
Why?
| | Akathisia, Drug-Induced | 1 | 2020 | 8 | 0.210 |
Why?
| | Infusions, Intraosseous | 1 | 2021 | 17 | 0.210 |
Why?
| | Lorazepam | 1 | 2020 | 25 | 0.210 |
Why?
| | Muscarinic Antagonists | 1 | 2020 | 30 | 0.210 |
Why?
| | Texas | 2 | 2017 | 178 | 0.200 |
Why?
| | Thiadiazoles | 1 | 2020 | 21 | 0.200 |
Why?
| | Treatment Outcome | 5 | 2021 | 9218 | 0.200 |
Why?
| | Delirium | 1 | 2020 | 63 | 0.200 |
Why?
| | Headache | 2 | 2018 | 154 | 0.200 |
Why?
| | Warfare | 2 | 2017 | 65 | 0.190 |
Why?
| | Hydroxocobalamin | 1 | 2020 | 30 | 0.190 |
Why?
| | Black Widow Spider | 1 | 2019 | 13 | 0.190 |
Why?
| | Spider Venoms | 1 | 2019 | 15 | 0.190 |
Why?
| | Tetrathionic Acid | 1 | 2019 | 3 | 0.190 |
Why?
| | Poisson Distribution | 1 | 2019 | 71 | 0.190 |
Why?
| | Cardiotoxicity | 1 | 2019 | 28 | 0.190 |
Why?
| | Poisons | 1 | 2019 | 18 | 0.190 |
Why?
| | Health Facilities | 1 | 2019 | 56 | 0.190 |
Why?
| | Intubation, Intratracheal | 2 | 2018 | 191 | 0.180 |
Why?
| | Models, Animal | 1 | 2021 | 391 | 0.180 |
Why?
| | Cystine | 1 | 2018 | 13 | 0.180 |
Why?
| | Vulnerable Populations | 1 | 2019 | 130 | 0.180 |
Why?
| | 2-Propanol | 1 | 2018 | 21 | 0.170 |
Why?
| | Dextropropoxyphene | 1 | 2017 | 5 | 0.170 |
Why?
| | Administration, Intravenous | 1 | 2018 | 139 | 0.170 |
Why?
| | Syncope | 1 | 2018 | 31 | 0.170 |
Why?
| | Hyperbaric Oxygenation | 1 | 2018 | 49 | 0.170 |
Why?
| | Face | 1 | 2019 | 172 | 0.170 |
Why?
| | Dizziness | 1 | 2018 | 71 | 0.170 |
Why?
| | Oximetry | 1 | 2018 | 88 | 0.170 |
Why?
| | Tramadol | 1 | 2017 | 19 | 0.170 |
Why?
| | Hypotension | 1 | 2018 | 128 | 0.170 |
Why?
| | Emergency Medicine | 2 | 2017 | 273 | 0.160 |
Why?
| | Vomiting | 1 | 2018 | 134 | 0.160 |
Why?
| | Infant, Premature, Diseases | 1 | 2018 | 91 | 0.160 |
Why?
| | Hemodynamics | 1 | 2022 | 1104 | 0.160 |
Why?
| | Afghan Campaign 2001- | 4 | 2018 | 141 | 0.160 |
Why?
| | Respiration, Artificial | 2 | 2023 | 560 | 0.160 |
Why?
| | Emergency Service, Hospital | 5 | 2019 | 1807 | 0.160 |
Why?
| | Military Medicine | 1 | 2017 | 73 | 0.160 |
Why?
| | Maternal Exposure | 1 | 2018 | 144 | 0.160 |
Why?
| | Telephone | 1 | 2017 | 166 | 0.160 |
Why?
| | Altitude | 1 | 2020 | 399 | 0.160 |
Why?
| | Laryngeal Masks | 1 | 2016 | 13 | 0.160 |
Why?
| | Toxicology | 1 | 2016 | 37 | 0.150 |
Why?
| | Monitoring, Physiologic | 1 | 2018 | 272 | 0.150 |
Why?
| | Airway Obstruction | 1 | 2018 | 155 | 0.150 |
Why?
| | Regression Analysis | 1 | 2019 | 1118 | 0.150 |
Why?
| | Drug Therapy, Combination | 1 | 2019 | 1006 | 0.150 |
Why?
| | Fatigue | 1 | 2018 | 303 | 0.150 |
Why?
| | Electrocardiography | 1 | 2019 | 656 | 0.150 |
Why?
| | Aspirin | 1 | 2018 | 331 | 0.140 |
Why?
| | Epilepsy | 1 | 2019 | 265 | 0.140 |
Why?
| | Acetaminophen | 1 | 2018 | 245 | 0.140 |
Why?
| | Survival Analysis | 1 | 2018 | 1410 | 0.140 |
Why?
| | Infant, Premature | 1 | 2018 | 454 | 0.140 |
Why?
| | Public Health | 1 | 2019 | 446 | 0.140 |
Why?
| | Dietary Supplements | 1 | 2017 | 453 | 0.130 |
Why?
| | Self Report | 1 | 2017 | 717 | 0.120 |
Why?
| | Patient Acceptance of Health Care | 1 | 2019 | 676 | 0.120 |
Why?
| | Research | 1 | 2016 | 465 | 0.120 |
Why?
| | United States | 5 | 2023 | 12598 | 0.120 |
Why?
| | Oxidative Stress | 1 | 2019 | 1231 | 0.120 |
Why?
| | Referral and Consultation | 1 | 2016 | 652 | 0.110 |
Why?
| | Time Factors | 2 | 2020 | 7041 | 0.100 |
Why?
| | Adult | 7 | 2022 | 32202 | 0.100 |
Why?
| | Male | 11 | 2021 | 60969 | 0.100 |
Why?
| | Surveys and Questionnaires | 2 | 2019 | 4769 | 0.100 |
Why?
| | Iraq | 2 | 2021 | 55 | 0.100 |
Why?
| | Afghanistan | 2 | 2021 | 67 | 0.090 |
Why?
| | Adolescent | 4 | 2021 | 18712 | 0.090 |
Why?
| | Injury Severity Score | 2 | 2021 | 543 | 0.080 |
Why?
| | Lung | 1 | 2020 | 3580 | 0.080 |
Why?
| | Child | 3 | 2021 | 17937 | 0.080 |
Why?
| | Double-Blind Method | 2 | 2020 | 1682 | 0.070 |
Why?
| | Middle Aged | 3 | 2019 | 28958 | 0.060 |
Why?
| | Ventilators, Mechanical | 1 | 2023 | 42 | 0.060 |
Why?
| | Explosions | 1 | 2021 | 13 | 0.050 |
Why?
| | War-Related Injuries | 1 | 2021 | 16 | 0.050 |
Why?
| | Diphenhydramine | 1 | 2020 | 35 | 0.050 |
Why?
| | Anti-Anxiety Agents | 1 | 2020 | 50 | 0.050 |
Why?
| | Blast Injuries | 1 | 2021 | 51 | 0.050 |
Why?
| | Sus scrofa | 1 | 2020 | 54 | 0.050 |
Why?
| | Medical Records | 1 | 2021 | 185 | 0.050 |
Why?
| | Inhalation Exposure | 1 | 2020 | 101 | 0.050 |
Why?
| | Flank Pain | 1 | 2019 | 7 | 0.050 |
Why?
| | Toxicokinetics | 1 | 2018 | 7 | 0.050 |
Why?
| | Toxicity Tests, Acute | 1 | 2018 | 9 | 0.050 |
Why?
| | Infusions, Intravenous | 1 | 2020 | 406 | 0.050 |
Why?
| | Terrorism | 1 | 2018 | 23 | 0.050 |
Why?
| | Antivenins | 1 | 2019 | 63 | 0.050 |
Why?
| | Mass Casualty Incidents | 1 | 2018 | 33 | 0.050 |
Why?
| | Quetiapine Fumarate | 1 | 2018 | 25 | 0.050 |
Why?
| | Tertiary Healthcare | 1 | 2018 | 26 | 0.040 |
Why?
| | Guideline Adherence | 1 | 2023 | 549 | 0.040 |
Why?
| | Wounds, Nonpenetrating | 1 | 2021 | 280 | 0.040 |
Why?
| | Tertiary Care Centers | 1 | 2017 | 129 | 0.040 |
Why?
| | Musculoskeletal Diseases | 1 | 2017 | 66 | 0.040 |
Why?
| | Dextromethorphan | 1 | 2016 | 21 | 0.040 |
Why?
| | Methanol | 1 | 2016 | 39 | 0.040 |
Why?
| | Human Experimentation | 1 | 2016 | 17 | 0.040 |
Why?
| | Antidepressive Agents | 1 | 2018 | 208 | 0.040 |
Why?
| | Ethics Committees, Research | 1 | 2016 | 41 | 0.040 |
Why?
| | Pain Management | 1 | 2019 | 303 | 0.040 |
Why?
| | Research Subjects | 1 | 2016 | 48 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2018 | 673 | 0.040 |
Why?
| | Length of Stay | 1 | 2020 | 1079 | 0.040 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 200 | 0.040 |
Why?
| | Prospective Studies | 2 | 2017 | 6324 | 0.040 |
Why?
| | Risk | 1 | 2018 | 945 | 0.040 |
Why?
| | Suicide, Attempted | 1 | 2018 | 299 | 0.040 |
Why?
| | Cadaver | 1 | 2016 | 303 | 0.040 |
Why?
| | Seasons | 1 | 2017 | 438 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2016 | 490 | 0.030 |
Why?
| | Survival Rate | 1 | 2018 | 1862 | 0.030 |
Why?
| | Young Adult | 2 | 2018 | 11032 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2018 | 5076 | 0.020 |
Why?
| | Infant | 1 | 2021 | 8124 | 0.020 |
Why?
| | Pregnancy | 1 | 2018 | 5316 | 0.020 |
Why?
| | Child, Preschool | 1 | 2021 | 9680 | 0.020 |
Why?
|
|
Ng's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|